Matinas BioPharma Holdings, Inc.

MAT9001: Prescription-Only Next Generation Omega-3

MAT9001 is our proprietary prescription-only omega-3 fatty acid-based composition under development for the treatment of cardiovascular and metabolic conditions

Learn More about MAT9001

Comparative Study Results

Enabling the Delivery of Life-Changing Medicines

Our differentiated lipid nano-crystal (LNC) drug delivery platform has the potential to address delivery issues associated with a range of molecules.

Learn More About Our LNC Platform

Mechanism of Action Video